A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots

Mol Genet Metab. 2012 Mar;105(3):519-21. doi: 10.1016/j.ymgme.2011.12.011. Epub 2011 Dec 21.

Abstract

Mucopolysaccharidosis type II (MPS II) or Hunter syndrome is a lysosomal storage disease caused by deficiency of iduronate-2-sulfatase (IDS). A convenient single-step fluorometric microplate enzyme assay has been developed and validated for clinical diagnosis of MPS II using dried blood spots (DBS). The assay compared well with a recently reported digital microfluidic method, from which it was adapted. Results show that this DBS assay is robust and reproducible using both technologies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Dried Blood Spot Testing*
  • Enzyme Assays / methods*
  • Fluorometry / methods
  • Humans
  • Iduronate Sulfatase / blood*
  • Iduronate Sulfatase / genetics
  • Microfluidic Analytical Techniques
  • Mucopolysaccharidosis II / blood
  • Mucopolysaccharidosis II / diagnosis*
  • Mucopolysaccharidosis II / enzymology

Substances

  • Iduronate Sulfatase